Arca
Skip to content

Castle Creek Biosciences, Inc.

6 private offerings reported to the SEC on Form D since 2016, $839.8M sold in all. Biotech, PA.

  • Form D offerings: 6
  • Reported sold: $839.8M
  • Newest: Feb 25, 2025

Every Form D Offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
Feb 25, 2025$75.0M$75.0MCastle Creek Biosciences, Inc.Biotech · PANot amended0001756702-25-000001
May 2, 2022$112.8M$112.8MCastle Creek Biosciences, Inc.Biotech · PANot amended0001756702-22-000002
Feb 3, 2022$11.8M$11.8MCastle Creek Biosciences, Inc.Biotech · PANot amended0001756702-22-000001
Jul 9, 2021$25.0M$25.0MCastle Creek Biosciences, Inc.Biotech · PANot amended0001756702-21-000002
Jan 21, 2020$54.6M$54.6MCastle Creek Pharmaceutical Holdings, Inc.Pharma · NJNot amended0001756702-20-000001
Oct 24, 2018$560.5M$560.5MCastle Creek Pharmaceutical Holdings, Inc.Pharma · NJNot amended0001756702-18-000001

SEC Profile

From the company's EDGAR record
Business address
Parsippany, Nj
Incorporated in
DE
SEC industry
Pharmaceutical Preparations
Former names
Castle Creek Pharmaceutical Holdings, Inc.
All SEC filings
CIK 1756702 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.